These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28108813)

  • 41. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
    Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
    Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
    Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
    Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
    Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophil-Derived Semaphorin 4D Induces Inflammatory Cytokine Production of Endothelial Cells via Different Plexin Receptors in Kawasaki Disease.
    Huang J; Wu S; Cao S; Zhu X; Zhang S
    Biomed Res Int; 2020; 2020():6663291. PubMed ID: 33381571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.
    Luo L; Feng S; Wu Y; Su Y; Jing F; Yi Q
    Pediatr Infect Dis J; 2019 Jan; 38(1):89-94. PubMed ID: 29601451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
    Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH
    J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
    Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
    Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
    Shuai S; Zhang H; Zhang R; Tang M; Luo E; Yang Y; Gao Y; Yue S; Liang H; Cai J
    J Pediatr (Rio J); 2023; 99(4):406-412. PubMed ID: 36977496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL; Zhao SL
    Med Sci Monit; 2018 Oct; 24():7264-7270. PubMed ID: 30307902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease.
    Assari R; Aghighi Y; Ziaee V; Sadr M; Rahmani F; Rezaei A; Sadr Z; Moradinejad MH; Raeeskarami SR; Rezaei N
    Int J Rheum Dis; 2018 May; 21(5):1120-1126. PubMed ID: 27455075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
    Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.
    Huang FC; Kuo HC; Huang YH; Yu HR; Li SC; Kuo HC
    BMC Pharmacol Toxicol; 2017 Jan; 18(1):3. PubMed ID: 28069066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
    Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
    Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
    Chen YL; Wang JL; Li WQ
    Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease.
    Li G; Wang T; Li J; Chen P; Jia P; Zhao J; Duan Y; Liu D; Xu X; Liu B
    Clin Chim Acta; 2020 Aug; 507():264-270. PubMed ID: 32387635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.